CI
Capital International’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.8M | Sell |
33,911
-9,241
| -21% | -$4.85M | 0.68% | 46 |
|
|
2025
Q1 | $27.4M | Buy |
43,152
+2,184
| +5% | +$1.39M | 1.19% | 23 |
|
|
2024
Q4 | $29.2M | Buy |
40,968
+5,197
| +15% | +$3.7M | 1.19% | 20 |
|
|
2024
Q3 | $37.6M | Buy |
35,771
+997
| +3% | +$1.05M | 1.62% | 13 |
|
|
2024
Q2 | $36.5M | Buy |
34,774
+3,741
| +12% | +$3.93M | 1.69% | 13 |
|
|
2024
Q1 | $29.9M | Buy |
31,033
+7,007
| +29% | +$6.74M | 1.43% | 16 |
|
|
2023
Q4 | $21.1M | Buy |
24,026
+464
| +2% | +$408K | 1.08% | 20 |
|
|
2023
Q3 | $19.4M | Sell |
23,562
-4,806
| -17% | -$3.96M | 1.12% | 18 |
|
|
2023
Q2 | $20.4M | Sell |
28,368
-2,919
| -9% | -$2.1M | 1.14% | 19 |
|
|
2023
Q1 | $25.7M | Sell |
31,287
-604
| -2% | -$496K | 1.54% | 10 |
|
|
2022
Q4 | $23M | Sell |
31,891
-598
| -2% | -$431K | 1.59% | 10 |
|
|
2022
Q3 | $22.4M | Buy |
32,489
+3,446
| +12% | +$2.37M | 1.56% | 10 |
|
|
2022
Q2 | $17.2M | Buy |
29,043
+1,387
| +5% | +$820K | 1.29% | 14 |
|
|
2022
Q1 | $19.3M | Buy |
27,656
+3,171
| +13% | +$2.21M | 1.1% | 18 |
|
|
2021
Q4 | $15.5M | Buy |
24,485
+104
| +0.4% | +$65.7K | 0.79% | 33 |
|
|
2021
Q3 | $14.8M | Sell |
24,381
-288
| -1% | -$174K | 0.8% | 31 |
|
|
2021
Q2 | $13.8M | Sell |
24,669
-1,139
| -4% | -$636K | 0.76% | 36 |
|
|
2021
Q1 | $12.2M | Sell |
25,808
-2,616
| -9% | -$1.24M | 0.74% | 33 |
|
|
2020
Q4 | $13.7M | Buy |
28,424
+319
| +1% | +$154K | 0.8% | 30 |
|
|
2020
Q3 | $15.7M | Buy |
28,105
+4,803
| +21% | +$2.69M | 1.07% | 25 |
|
|
2020
Q2 | $14.5M | Sell |
23,302
-264
| -1% | -$165K | 1.36% | 21 |
|
|
2020
Q1 | $11.5M | Buy |
+23,566
| New | +$11.5M | 1.29% | 21 |
|
|
2018
Q3 | – | Sell |
-8,223
| Closed | -$2.84M | – | 162 |
|
|
2018
Q2 | $2.84M | Sell |
8,223
-99
| -1% | -$34.2K | 0.5% | 66 |
|
|
2018
Q1 | $2.87M | Buy |
+8,322
| New | +$2.87M | 0.51% | 64 |
|